Skip to main content
NewslettersWatchlist

Intellia Thera CS(NTLA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Intellia Thera CS

40 Erie Street Suite 130
Cambridge MA 02139 USA
P: 857-285-6200
http://www.intelliatx.com

Profile

Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the therapy and ex vivo programs that use CRISPR to create the therapy by using engineered human cells.'

Key Executives

NameTitle
John M. LeonardCEO/Director/President
Glenn GoddardCFO/Chief Accounting Officer/Executive VP/Treasurer
Laura Sepp-LorenzinoChief Scientific Officer/Executive VP
James BastaExecutive VP/General Counsel/Secretary
David LebwohlChief Medical Officer/Executive VP
Derek HicksExecutive VP/Other Executive Officer
Eliana ClarkChief Technology Officer/Executive VP

More from The Globe

investor newsletter
A look at how people are using the best all-around investing product. Plus, top stock picks from our new Readers’ Portfolio
ETF or Exchange Traded Fund text on black block
The close: Month-end repositioning spurs late-day stock rally
Trader Anthony Confusione works on the floor of the New York Stock Exchange, Thursday, May 30.
Why this money manager thinks investors should get off the sidelines but still be defensive
Illustration of Chris Kerlow for The Mover. June 23/24, 2023. Illustration by Joel Kimmel
globe advisor weekly newsletter
Canadian investors are ‘underserved’ in alternative investments and private capital
Investors want greater clarity from their advisors around what RI means and how it can fit their portfolios.
Why rising interest in traditional fixed income is not affecting alternatives
A man looks up as he leans a red ladder against a tall stack of coins that is topped with an interest rate symbol.
Fund houses buy up ‘alts’ specialists to move beyond equities and bonds
FILE PHOTO: Larry Fink, Chief Executive Officer of BlackRock, takes part in the Yahoo Finance All Markets Summit in New York, U.S., February 8, 2017. REUTERS/Lucas Jackson
opinion
Four reasons why wealthy investors should hold farmland in their portfolios
Andrea Gruza
Four ways to create more diversified and resilient portfolios
One of a set. Graphic Arrow on abstract background.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.